BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
46 hedge funds and large institutions have $1.05M invested in BRAINSTORM CELL THERAPUTC in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
52% less call options, than puts
Call options by funds: $23K | Put options by funds: $48K
Holders
46
Holding in Top 10
–
Calls
$23K
Puts
$48K
Top Buyers
| 1 | +$27.3K | |
| 2 | +$19.8K | |
| 3 | +$19K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.78K |
Top Sellers
| 1 | -$41K | |
| 2 | -$40.5K | |
| 3 | -$35.1K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$27.3K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$19.9K |